Cancer as a reprogramming-like disease: Implications in tumor development and treatment
- 1 April 2010
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 20 (2), 93-97
- https://doi.org/10.1016/j.semcancer.2010.02.001
Abstract
No abstract availableFunding Information
- FEDER
- MICINN
- FIS
- Junta de Castilla y León
- MEC OncoBIO Consolider-Ingenio 2010
- NIH Grant
- Sandra Ibarra Foundation
- Group of Excellence Grant
This publication has 46 references indexed in Scilit:
- Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell ContentCell, 2010
- Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypesThe EMBO Journal, 2009
- The Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem CellsCell, 2009
- Direct reprogramming of human neural stem cells by OCT4Nature, 2009
- The promises and perils of p53Nature, 2009
- A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrityNature, 2009
- Suppression of induced pluripotent stem cell generation by the p53–p21 pathwayNature, 2009
- Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformationNature, 2008
- Cancer induction by restriction of oncogene expression to the stem cell compartmentThe EMBO Journal, 2008
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006